Period Ending | Jun 29, 2012 | Mar 30, 2012 | Dec 30, 2011 | Sep 29, 2011 |
---|
Total Revenue
|
4,477,000
|
4,048,000
|
3,973,000
|
3,944,000
| Cost of Revenue | 682,000 | 679,000 | 656,000 | 605,000 | |
Gross Profit
|
3,795,000
|
3,369,000
|
3,317,000
|
3,339,000
| |
|
Operating Expenses |
|
Research Development | 826,000 | 736,000 | 851,000 | 761,000 |
|
Selling General and Administrative | 1,307,000 | 1,082,000 | 1,231,000 | 1,979,000 |
|
Non Recurring |
-
|
-
|
-
|
-
|
|
Others | 73,000 | 74,000 | 73,000 | 74,000 |
|
|
|
Total Operating Expenses |
-
|
-
|
-
|
-
| | |
Operating Income or Loss
|
1,589,000
|
1,477,000
|
1,162,000
|
525,000
| |
|
Income from Continuing Operations |
|
Total Other Income/Expenses Net | 124,000 | 124,000 | 84,000 | 87,000 |
|
Earnings Before Interest And Taxes | 1,713,000 | 1,601,000 | 1,246,000 | 612,000 |
|
Interest Expense | 256,000 | 235,000 | 195,000 | 158,000 |
|
Income Before Tax | 1,457,000 | 1,366,000 | 1,051,000 | 454,000 |
|
Income Tax Expense | 191,000 | 182,000 | 117,000 |
-
|
|
Minority Interest |
-
|
-
|
-
|
-
|
|
|
|
Net Income From Continuing Ops | 1,266,000 | 1,184,000 | 934,000 | 454,000 | |
|
Non-recurring Events |
|
Discontinued Operations |
-
|
-
|
-
|
-
|
|
Extraordinary Items |
-
|
-
|
-
|
-
|
|
Effect Of Accounting Changes |
-
|
-
|
-
|
-
|
|
Other Items |
-
|
-
|
-
|
-
| | |
Net Income
|
1,266,000
|
1,184,000
|
934,000
|
454,000
| Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| |
Net Income Applicable To Common Shares
|
1,266,000
|
1,184,000
|
934,000
|
454,000
|
|